Contact us

SeqOne S.A.S

SeqOne S.A.S.
22 Rue Durand
34000 Montpellier, France
+33 (0) 9 54 40 42 84

FDA approves gene-altering leukemia therapy in US

The FDO today approved a leukemia treatment involving patient genetic modification

The New York times today reported that the FDA had approved the first therapy that involves human genetic modification.   The procedure developed by Novartis to combat leukemia will be the first gene therapy ever to reach the market in the US.  Read the full article here.

Next generation genomic analysis for next generation healthcare